Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Barbara L. McAneny, MD, FASCO, MACP, a board-certified medical oncologist/hematologist from Albuquerque, NM, became the 173rd president of the American Medical Association (AMA) in June 2018, serving as its chair in 2015–2016. Dr. McAneny is a fellow and former member of the board of directors of the American Society of Clinical Oncology (ASCO), a master of the American College of Physicians, and a …
Microsoft Word - 1-Bylaws-April 2016.doc ASSOCIATION OF COMMUNITY CANCER CENTERS BYLAWS Adopted Unanimously by House of Delegates - March 1984 Amended by Vote of House of Delegates March 1988 March 1990 March 1991 March 1993 March 1994 March 1998 March 2001 March 2002 March 2003 March 2004 April 2008 …
TOGETHER W E A R E JOIN US! STRONGER ASSOCIATION OF COMMUNITY CANCER CENTERS ACCC is a powerful network of more than 23,000 multidisciplinary practitioners and 2,500 cancer programs and practices nationwide. ACCC represents cancer care professionals from every discipline in oncology—working in every care delivery setting. From private practices to …
Important Requirements of COVID-19 Registry Technology ASCO Survey on COVID-19 in Oncology (ASCO) Registry Closing the COVID-19 and Cancer Data Gap Friday, June 12, 2020 This webcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., and Pfizer, Inc. Richard L. Schilsky, MD, FACP, FSCT, FASCO Chief Medical Officer, Executive Vice …
June 12, 2020
ACCC and the American Society of Clinical Oncology (ASCO) share how the COVID-19 pandemic presents a unique opportunity to better understand the effects of a disease outbreak on the delivery of high-quality cancer care and research. (June 12, 2020)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ADAKVEO safely and effectively. See full prescribing information for ADAKVEO. ADAKVEO® (crizanlizumab-tmca) injection, for intravenous use Initial U.S. Approval: 2019 ----------------------------INDICATIONS AND USAGE--------------------------- ADAKVEO is a selectin blocker indicated to reduce …
At the recent American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program, ACCC presented seven abstracts that capture data spanning the organization’s diverse provider education portfolio.
TECENTRIQ Prescribing Information HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TECENTRIQ safely and effectively. See full prescribing information for TECENTRIQ. TECENTRIQ® (atezolizumab) injection, for intravenous use Initial U.S. Approval: 2016 RECENT MAJOR CHANGES−−−− Indications and Usage, Non-Small …
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AVASTIN safely and effectively. See full prescribing information for AVASTIN. AVASTIN (bevacizumab) injection, for intravenous use Initial U.S. Approval: 2004 -------------------------RECENT MAJOR CHANGES----------------------------- Indications and Usage, Hepatocellular Carcinoma …
AVASTIN Hepatocellular Carcinoma (HCC) SAMPLE CODING Hepatocellular Carcinoma (HCC) TYPE CODE DESCRIPTION Diagnosis: ICD-10-CM C22.0 Liver cell carcinoma, hepatocellular carcinoma C22.8 Malignant neoplasm of liver, primary, unspecified as to type Drug: HCPCS J9035 Injection, bevacizumab, 10 mg Drug: NDC Note: Payer requirements regarding use of a 10-digit or 11-digit …
TECENTRIQ Hepatocellular Carcinoma (HCC) Billing Codes 1 of 2 for ® (atezolizumab) Please see full Prescribing Information for additional Important Safety Information. Hepatocellular Carcinoma (HCC) TYPE CODE DESCRIPTION Diagnosis: ICD-10-CM C22.0 Liver cell carcinoma, hepatocellular carcinoma C22.8 Malignant neoplasm of liver, primary, unspecified …
Learn how two cancer programs used a unique quality improvement model to improve care for lung cancer patients who are uninsured or on Medicaid.
Amrita Goyal, MD et al., Department of Dermatology, University of Minnesota, Minneapolis, MN View Poster
PowerPoint Presentation Cancer and COVID19: Infection Prevention Steven Pergam, MD, MPH Associate Member, VIDD & CRD, FHCRC Director, Infection Prevention, SCCA Friday, June 5, 2020 This webcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., and Pfizer, Inc. Focus on Goals • Protect employees • No provider to patient transmission …
Racism attacks people’s physical and mental health and is an ongoing public health crisis. The structural inequities and social injustice that African Americans and other people of color endure have been amplified by the coronavirus pandemic as they bear a greater burden of COVID-19 due to lesser access to testing, treatment, and care, along with higher rates of hospitalization and death. And despite …
June 5, 2020
Join Steven A. Pergam, MD, MPH, Medical Director of Infection Prevention, Seattle Cancer Care Alliance, for an overview of the applicability of existing guidelines to your program, discussion of several COVID infection prevention scenarios, and a look ahead. (June 5, 2020)
TECENTRIQ Prescribing Information HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TECENTRIQ safely and effectively. See full prescribing information for TECENTRIQ. TECENTRIQ® (atezolizumab) injection, for intravenous use Initial U.S. Approval: 2016 RECENT MAJOR CHANGES−−−− Indications and Usage, Non-Small …
102681_003_NowAprvd_BRFM_Ltr_Lo10_C03 TECENTRIQ® NOW HAS 5 APPROVALS IN LUNG CANCER A new option in PD-L1–high 1L metastatic NSCLC Important Safety Information Serious and sometimes fatal adverse reactions occurred with TECENTRIQ treatment. Warnings and precautions include immune-mediated serious adverse reactions, including pneumonitis, hepatitis, colitis, endocrinopathies, and other …
Racism attacks people’s physical and mental health and is an ongoing public health crisis. The structural inequities and social injustice that African Americans and other people of color endure have been amplified by the coronavirus pandemic as they bear a greater burden of COVID-19 due to lesser access to testing, treatment, and care, along with higher rates of hospitalization and death. And despite …
Slide 1 Department of Hematology, Oncology & Transplantation Triple Aberrant Prostate Cancer (TAPC) – Aggregate role of aberrations in TP53, PTEN and RB1 on ETS gene fusions and prognosis in metastatic castrate resistant prostate cancer. Ashraf Shabaneh1 and Allison Watson2, Jinhua Wang1, Scott Dehm3, Arpit Rao4, Charles Ryan4 1Institute for Health Informatics, Masonic Cancer …